Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 10.


Escriu, Carles ORCID: 0000-0003-3638-3202 and Field, John K ORCID: 0000-0003-3951-6365
(2016) Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer. JOURNAL OF THORACIC DISEASE, 8 (9). pp. 2357-2359.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 7 more authors) (2023) The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (2). 1746-.


Banna, Giuseppe L, Cantale, Ornella, Muthuramalingam, Sethupathi, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Signori, Alessio, McKenzie, Hayley, Escriu, Carles ORCID: 0000-0003-3638-3202
et al (show 7 more authors) (2022) Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study. INTERNATIONAL IMMUNOPHARMACOLOGY, 110. 108985-.


Piddock, Katherine, Nautiyal, Hritik, Ahmed, Mohammed, Barron, Melanie, Bhalla, Neeraj, Cook, Tim, Cubbin, Sarah, Davis, Gershan, Dobson, Rebecca, Escriu, Carles
et al (show 10 more authors) (2022) Frailty, comorbidity and cardiovascular risk assessment in older patients with lung cancer. .


Gillespie, Conor S, Mustafa, Mohammad A, Richardson, George E, Alam, Ali M ORCID: 0000-0001-6014-3263, Lee, Keng Siang, Hughes, David M ORCID: 0000-0002-1287-9994, Escriu, Carles ORCID: 0000-0003-3638-3202 and Zakaria, Rasheed ORCID: 0000-0001-6826-2662
(2023) Genomic alterations and the incidence of brain metastases in advanced and metastatic non-small cell lung cancer: a systematic review and meta-analysis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 18 (12). S1556-0864(23)00638-X-S1556-0864(23)00638-X.


Anpalakhan, Shobana, Huddar, Prerana, Behrouzi, Roya, Signori, Alessio, Cave, Judith, Comins, Charles, Cortellini, Alessio, Addeo, Alfredo, Escriu, Carles ORCID: 0000-0003-3638-3202, McKenzie, Hayley
et al (show 9 more authors) (2023) Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. FRONTIERS IN ONCOLOGY, 13. 1163768-.


Schwartzberg, Lee S, Horinouchi, Hidehito, Chan, David, Chernilo, Sara, Tsai, Michaela L, Isla, Dolores, Escriu, Carles ORCID: 0000-0003-3638-3202, Bennett, John P, Clark-Langone, Kim, Svedman, Christer
et al (show 1 more authors) (2020) Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance. NPJ PRECISION ONCOLOGY, 4 (1). 15-.


Haragan, Alexander ORCID: 0000-0002-9747-563X
(2021) PD-L1 expression and prediction of response to immune modulators in non-small cell lung cancer; reasons for its fragility and strategies to reduce it. PhD thesis, University of Liverpool.


Haragan, Alexander ORCID: 0000-0002-9747-563X, Gosney, John, Field, John ORCID: 0000-0003-3951-6365, Davies, michael ORCID: 0000-0002-7609-4977, Escriu, Carles ORCID: 0000-0003-3638-3202 and Gruver, Aaron
(2019) PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases. .


Sallam, Mostafa, Wong, Helen and Escriu, Carles ORCID: 0000-0003-3638-3202
(2019) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network. BMC PULMONARY MEDICINE, 19 (1). 195-.

This list was generated on Sat Feb 10 16:11:27 2024 GMT.